Centrient Pharmaceuticals appoints Rex Clements as Chief Executive Officer after Karl Rotthier decides to step down from the role
Centrient Pharmaceuticals, the global leader in the production and commercialisation of sustainable antibiotics, next-generation statins and anti-fungals, is announcing that Karl Rotthier has decided to step down as CEO after having built a highly successful company over the last ten years and managing a smooth transition to the new ownership under Bain Capital.read more
employees around the globe
years of innovation
years of antibiotics
Close to customers everywhere
Our manufacturing sites and sales offices around are the cornerstones of our customer and supplier relationships around the globe, providing on-the-ground support and ensuring security of supply.